RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Enavate Sciences
E

Enavate Sciences portfolio

Enavate Sciences has 1 portfolio company on record at Recent Funding. Its most recent investment on record is Normunity's $75M Series B+ round in January 2025, which it led, alongside YK Bioventures, Taiho Ventures, Sanofi Ventures and 6 others. That company is in Health and bio.

Type: Investor.
Portfolio on Recent Funding: 1.
Deals, last 12 months: 0.
Rounds led: 1 of 1.
Capital in their rounds: $75M.
Latest deal: Normunity · Jan 13, 2025.

What Enavate Sciences invests in

How Enavate Sciences invests

StageDealsCapital in rounds
Series B+ 1 100%$75M

Share is of the 1 round on Recent Funding that name Enavate Sciences. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Enavate Sciences portfolio companies

CompanyRound with Enavate SciencesTotal raisedLatest raise
NNormunity
Health and bio
Series B+ · $75M · lead$140MJan 13, 2025
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

Portfolio companies are the companies on Recent Funding with a round that lists Enavate Sciences, which is a subset of its real portfolio. API: /api/v1/investors/enavate-sciences (get a free API key). More: the most active VC firms and new venture capital funds.